SCHEMBL16632831

SCHEMBL16632831

C=CCc1cc(C(=O)O)c(O)c(O)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGB1 P09429 2/20 0.41
CXCL12 P48061 2/20 0.41
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 3/20 0.38
HPGD P15428 2/20 0.38
ALDH1A1 P00352 1/20 0.38
KDM4E B2RXH2 2/20 0.37
TSHR P16473 2/20 0.37
GAA P10253 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GABRA1 P14867 2/20 0.36
GABRB2 P47870 2/20 0.36
MAPK1 P28482 1/20 0.36
CYP2C9 P11712 1/20 0.35
ALOX12 P18054 1/20 0.35
ATIC P31939 1/20 0.35
PTPN1 P18031 3/20 0.35
LDHA P00338 2/20 0.35
LDHB P07195 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3965068 0.80 HSD17B10 (0.41) HMGB1CXCL12MEN1KMT2AHSD17B10
SCHEMBL2053985 0.78 GABRA1 (0.41) HMGB1CXCL12HSD17B10HPGDALDH1A1
SCHEMBL29225947 0.78 GABRA1 (0.41) HMGB1CXCL12HSD17B10HPGDALDH1A1
SCHEMBL11061927 0.78 KDM4E (0.41) MEN1KMT2AHSD17B10ALDH1A1KDM4E
SCHEMBL8072029 0.77 GABRA1 (0.46) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL16035544 0.77 GABRA1 (0.43) MEN1KMT2AHSD17B10HPGDALDH1A1
SCHEMBL3364581 0.75 PTPN1 (0.49) HMGB1CXCL12MEN1KMT2AHSD17B10
SCHEMBL4074396 0.75 ALDH1A1 (0.42) HMGB1CXCL12HSD17B10HPGDALDH1A1
SCHEMBL9960069 0.75 ALDH1A1 (0.47) HMGB1CXCL12MEN1KMT2AHSD17B10
SCHEMBL22160245 0.74 GABRA1 (0.38) HMGB1CXCL12HSD17B10HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902986-B2 Enterobactin conjugates and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-02-27 US disclosed
WO-2015057958-A2 ENTEROBACTIN CONJUGATES AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-04-23 WO disclosed
US-20150105337-A1 ENTEROBACTIN CONJUGATES AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105337-A1 ENTEROBACTIN CONJUGATES AND USES THEREOF BTD, VIP, SLC10A2 HMGB1 51/4885CXCL12 1458/4885MEN1 1430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.